Retraction: Phytochemicals from plants to combat cardiovascular disease (Curr. Med. Chem., (2012) 19, 14, (2242-2251), 10.2174/092986712800229078);Phytochemicals from plants to combat cardiovascular disease

Current Medicinal Chemistry

Volumn 19, Issue 14, 2012, Pages 2242-2251

  Vasanthi, H R ^a   ShriShriMal, N ^a   Das, D K ^a,b  

^a PONDICHERRY UNIVERSITY   (India)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Cardioprotection; Flavonoids; Phytochemicals; Polyphenols; Terpenoids

Indexed keywords

ALKALOID DERIVATIVE; CATECHIN; CUCURBITACIN; CURCUMA LONGA EXTRACT; DAIDZEIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GALLOCATECHIN; GARLIC EXTRACT; GENISTEIN; GINKGO BILOBA EXTRACT; GREEN TEA EXTRACT; HESPERIDIN; ISOFLAVONE; MYRICETIN; NARINGENIN; OCIMUM SANCTUM EXTRACT; ONION EXTRACT; PELARGONIDIN; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; STEROL; TERMINALIA ARJUNA EXTRACT; TERPENOID; UNINDEXED DRUG;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CITRULLUS; COMMIPHORA; CONGESTIVE HEART FAILURE; CONVALLARIA; CURCUMA LONGA; DIABETES MELLITUS; DIOSCOREA BULBIFERA; FABACEAE; FENUGREEK; GARLIC; GINKGO BILOBA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; NONHUMAN; OBESITY; OCIMUM TENUIFLORUM; REPERFUSION INJURY; TEA; TERMINALIA ARJUNA; VIBURNUM;

EID: 84860663434     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986732732200825103533     Document Type: Erratum

References (141)

1. Chaitan Khosla.; Jay D Keasling. Metabolic engineering for drug discovery and development. Nature Rev. Drug. Discov., 2003, 2, 1019-1023.
2. Fabricant, D. S.; Farnsworth, N. R. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect., 2001, 109, 69-75. (Pubitemid 32303231)
3. Mohan, V.; Sandeep, S.; Deepa, R.; Shah, B.; Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J. Med. Res., 2007, 125,217-230. (Pubitemid 46805444)
4. Thomas, A. Gazino.; Asaf, Bitton; Swafika, Abrahamas-Gessel.; Adriana, Murphy. Growing epidemic of coronary heart disease in low and middle income countries. Curr Probl Cardiol., 2010, 35(2), 72-115
5. F. Brian, Choudhary, H.; Asan, J. Compton. Risk factors for coronary artery disease. Med. Overview, 2011, 164-163.
6. Leeder, S; Raymond S.; Greenberg H. A Race against time: The challenge of cardiovascular disease in developing countries. New York. Trustees of Columbia University, 2004.
7. [Dwivedi, S.; Udupa, N. Terminalia arjuna: pharmacognosy, phytochemistry, pharmacology and clinical use. Fitoterpia, 1989, 60, 413-420. (Pubitemid 20016630)
8. Shatvalekar, S. AtharvaVeda Samhita, 1st ed. Balsad, Maharashtra, India, 1943, P. 25.
9. Gauthaman, K.; Banerjee S. K.; Dinda A. K.; Ghosh, C. C.; Maulik, S. K. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury, role of antioxidant enzymes and heat shock protein. J. Ethnopharmaco., 2005, 96, 403-409. (Pubitemid 41556590)
10. Dwivedi, S.; Agarwal, P. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug in coronary heart disease. J. Assoc. Physicians India., 1994, 42, 287-289.
11. Duwiejua, M.; Zeitlin, I. J.; Waterman, PG.; Chapman, J.; Mhango, G. J.; Proven, G. J. Anti inflammatory activity of resins from some species of plant family Bruseraceae. Planta medica, 1993, 59, 12-16. (Pubitemid 23055638)
12. Chander, R.; Khana, A. K.; Pratap, R. Antioxidant activity of guggulsterone the active principle of gugulipid from Commiphora mukul. J. Med Aromatic plants Sci., 2002, 24, 370-374.
13. Jellin, J. M.; Gregory, P. J.; Batz, F. Pharmacist's letter /presciber's letter natural medicine comprehensive database. 5th ed. Stockton, Calif: Therapeutic Research Faculty, 2003, 379-82.
14. Kossel, A. Uber die chemishe Zusammensetzung der Zelle Arch. Physiol., 1891,181.
15. Penny, M.; Etherton, K.; Kari, D.; Hecker, Bonanome, A.; Coval, S. M.; Amy, E.; Binkosaki, B. S.; Hilpert, K. F.; Griel, A. E.; Etherton, T. D. Bioactive compounds in foods: their role in prevention of CVD and cancer. Am. J. Med., 2002, 113(9), 71-88.
16. Bravo, L. B. Polyphenols: chemistry, dietary sources, metabolism and nutritional significance. Nutr. Rev., 1998, 56,317-33.
17. Crof, K. D. The chemistry and biological effects of flavonoids and phenolic acid. Ann. NY. Acad. Sci., 1998, 854,435-42.
18. Claudine, Manach.; Andrej, Mazur.; Augustin, Scarbert. Polyphenols and prevention of cardiovascular diseases. Curr Opion Lipidol., 2005, 16,000-000.
19. Heller, W. Forkmann, G. Biosynthesis, in the flavonoids. Advances in Reserch since 1986. Harborne JB ed. Chapman and Hall Ltd., London, pp. 499-535.
20. Julie, A. Ross; Christine, M. Kasum. Dietary flavonoids: Bioavailability, Metabolic Effects, and Safety. Annu. Rev. Nutr., 2002, 22, 19-34.
21. Rohmer, M. The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat Prod Rep., 1999, 16, 565-74. (Pubitemid 29501611)
22. Zulak, K.; Liscombe, D.; Ashihara, H.; Facchini, P. Alkaloids. Plant secondary metabolism in diet and human health. Oxford Blackwell Publishing, 2006, 102-36.
23. Kim, K. J.; Lee, M. S.; Jo, K.; Hwang, J. K. Piperidine alkaloids from Piper retrofractum Vahl. protect against high-fat diet-induced obesity by regulating lipid metabolism and activating AMP-Activated protein kinase. Biochem Biophys Res Commun., 2011, 411(1), 219-25.
24. Moura, D. J.; Richter, M. F.; Boeira, J. M.; Henriques, J. A.; Saffi, J. Antioxidant properties of beta carboline alkaloids are related to their antimutagenic and antigenotoxic activities. Adv. Access. Pub., 2007, 22(4), 125-9.
25. Vijaylakshami, Ravichandiran, Malakordi, V.; Hemlatha, Jayakumari. Antianaphylactic and anti-inflammatory activities of a bioactive alkaloid from root bark of Plumeria acutifolia poir, Indian J Pharma Res., 2011, 10(3), 525-533.
26. Beaglehole, R. International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev., 1990, 12, 1-15.
27. A. Sekher.; Pannala, T. S.; Chan, P. J.; O'Brien.; C. A. Rice-Evans. Flavonoid B-ring chemistry and antioxidant activity: fast reaction kinetics, Biochem Biophys Res Commun, 2001, 282, 1161-1168. (Pubitemid 32912847)
28. S. Burda; W. Oleszek. Antioxidant and antiradical activities of flavonoids. J. Agric. Food. Chem., 2001, 49, 2774-2779. (Pubitemid 32826067)
29. Anderson, J. W; Johnstone, B. M; Cook-Newell, M. E. Meta-Analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med., 1995, 333,276-282.
30. Potter, S. M. Soy protein and cardiovascular diseases: the impact of bioactive components in soy. Nutr Rev., 1998, 56, 231-235. (Pubitemid 28419770)
31. Jenkins, D. J; Kendall, C. W; Jackson, C. J; Connelly, P. W; Parker, T; Faulkner, D; Vidgen, E; Cunnane, S. C; Leiter, L. A; Josse, R. G. Effects of high-And low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr., 2002, 76, 365-372. (Pubitemid 34804058)
32. Rimbach, G.; Boesch-Saadatmandi, C.; Frank, J.; Fuchs, D.; Wenzel, U.; Daniel, H.; Hall, WL; Weinberg, PD. Dietary isoflavones in the prevention of cardiovascular disease-A molecular perspective. Food Chem Toxicol., 2008, 46, 1308-1319. (Pubitemid 351258194)
33. Damasceno, NRT; Apolinário, E.; Flauzino, F. D; Fernandes, I.; Abdalla, DSP. Soy isoflavones reduce electronegative low-density lipoprotein (LDL-) and anti-LDL-Autoantibodies in experimental atherosclerosis. Eur J Nutr., 2007, 46,125-132. (Pubitemid 46481363)
34. Ali, A. A.; Velasquez, M. T.; Hansen, C. T.; Mohamed, A. I.; Bhathena, S. J. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem., 2004, 15,583-590. (Pubitemid 39470212)
35. McVeigh, B. L.; Dillingham, B. L.; Lampe, J. W.; Duncan, A. M. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr., 2006, 83,244-251. (Pubitemid 44713184)
36. Yamori, Y.; Teramoto, T.; Noguchi, T.; Sekine, Y.; Nara, Y.; Ikeda, K. Soy isoflavone, daidzein, attenuates post variectomized blood pressure elevation by accelerating nitric oxide production . J Nutr., 2000, 130, 739S.
37. Babu, P. V.; Liu, D. Green tea catechins and cardiovascular health-An update. Curr Med Chem., 2008, 15(18), 1840-50.
38. Heim, KE; Tagaliaferro, AR; Bobliya DJ. Flavonoid antioxidants: Chemistry, metabolism and structure activity relationship. J Nutr Biochem., 2002, 10, 572-584.
39. Cholbi, M. R.; Paya, M.; Alcaraz, M. J. Inhibitory effects of phenolic compounds on CCl4 induced microsomal lipid peroxidation. Experientia, 1991, 47(2), 195-9.
40. Balentine, DA; Wiseman, SA; Bouwens, LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr., 1997, 37(8), 693-704. (Pubitemid 127349613)
41. Dufresne, CJ; Farnworth, ER. A review of latest research findings on the health promotion properties of tea. J Nutr Biochem., 2001, 12(7), 404-421. (Pubitemid 32633828)
42. Shahidi F. Nahrung. Antioxidants in food and food antioxidants. Nr., 2000, 44, 158-163.
43. Miura, Y.; Chiba, T.; Tomita, I.; Koizumi, H.; Miura, S.; Umegaki, K.; Hara, Y.; Ikeda, M.; Tomita, T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr., 2001, 131(1), 27-32. (Pubitemid 32060618)
44. Negishi, H.; Xu, J. W.; Ikeda, K.; Njelekela, M.; Nara, Y.; Yamori, Y. Black and green tea polyphenols attenuate blood pressure increases in stroke prone spontaneously hypertensive rats. J Nutr., 2004, 134(1), 38-42. (Pubitemid 38057420)
45. Babu, PV; Sabitha, KE; Shyamaladevi, CS. Therapeutic effect of green tea extract on oxidative stress in aorta and heart of stretozotocin diabetic rats. Chem Biol Interact., 2006, 162(2), 114-20. (Pubitemid 44189959)
46. Stangl, V.; Dreger, H.; Stangl, K.; Lorenz, M. Molecular targets of tea polyphenols in cardiovascular system. Cardiovasc Res., 2007, 73(2), 348-58. (Pubitemid 44937692)
47. Sumpio, B. E.; Cordova, A. C.; Berke-Schlessel, D. W.; Qin, F.; Chen, QH. Green tea, the Asian Paradox' and cardiovascular disease. J Am Coll Surg., 2006, 202(5), 813-25.
48. Kang, W. S.; Lim, I. H.; Yuk, D. Y.; Chung, K. H.; Park, J. B.; Yoo, H. S.; Yun, Y. P. Antithrombotic activities of green tea catechins and (-) epigallocatechin gallate. Thromb Res., 1999, 96, 229-37.
49. Jin,Y. R.; Im, J. H.; Park, E. S.; Cho, M. R.; Han, X. H.; Lee, J. J.; Lim, Y.; Kim, T. J.; Yun, Y. P. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLC gamma2 phosphorylation, elevation of PGD2 production and maintaining calcium ATPase activity. J Cardiovasc Pharmacol., 2008, 51, 45-54.
50. Hollman, P.; Van Trijp, J.; Buysman, M.; Gaag, M.; Mengelers, M.; de Vries, J.; Katan, M. Relative bioavailability of the various antioxidant flavonoid quercetin from various foods in man. FEBS Let, 1997,418, 152-156. (Pubitemid 27514436)
51. Carolina, Aliaga; Eduardo, A. Lissi. Comparison of the free radical scavenger activities of quercetin and rutin An experimental and theoretical study. Canadian Journal of Chemistry, 2004, 82(12), 1668-73. (Pubitemid 40767564)
52. Punithavathi, VR; Stanely Mainzen Prince P. The cardioprotective effects of a combination of quercetin and alpha tocopherol on isoproteronol induced myocardial infracted rats. J. Biochem Mol. Toxicol., 2011, 25(1), 28-40.
53. Osman, H. E.; Maalej, N.; Shanmuganayagam, D.; Folts, J. D. Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys. J Nutr., 1998, 128, 2307-12. (Pubitemid 29012976)
54. Havsteen, B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol., 1983, 32, 1141-8.
55. Welton, A. F.; Tobias, L. D.; Fiedler-Nagy, C.; Anderson, W.; Hope, W.; Meyers, K.; Coffey, J. W. Effect of flavonoids on arachidonic acidmetabolism. Prog Clin Biol Res., 1986, 213, 231-42.
56. Alcocer, F.; Whitley, D.; Salazar Gonzales, J. F., Jordan, W. D.; Sellers, M. T.; Eckhoff, D. E.; Suzuki, K.; Macrae, C.; Bland, K. I. Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery, 2002, 131,198-204. (Pubitemid 34169547)
57. Yoshizumi, M.; Tsuchiya, K.; Kirima, K.; Kyaw, M.; Suzuki, Y.; Tamaki, T. Quercetin inhibits Shc-And phosphatidylinositol 3-kinase-mediated c jun Nterminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol., 2001, 60, 656-60.
58. Cui, J.; Cordis, G. A.; Tosaki, A.; Maulik, N.; Das, D. K. Reduction of Myocardial Ischemia Reperfusion Injury with Regular Consumption of Grapes. Annals of the New York Academy of Sciences, 2002, 957, 302-7. (Pubitemid 34721678)
59. Aprikian, O.; Levrat-Verny, M.; Besson, C.; Busserolles, J.; Remesy, C.; Demigne, C. Apple favourably affects parameters of cholesterol metabolism and of anti-oxidative protection in cholesterol fed rats. Food Chem., 2001, 75, 445-452. (Pubitemid 33065644)
60. Punithavathi, V. R.; P. Stanely Manizen Prince. Combined effects of quercetin and a-Tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats. Chem. Biol. Interact., 2009, 181(3), 322-327.
61. Nair, M. P.; Mahajan, S.; Reynolds, J. L.; Aalinkeel, R.; Nair, H.; Schwaltz, J. A.; Kanaswami, C. The Flavonoid Quercetin Inhibits Proinflammatory Cytokine (Tumor Necrosis Factor Alpha) Gene Expression in Normal Peripheral Blood Mononuclear Cells via Modulation of the NF-LV System. Clin Vaccine Immunol., 2006, 13(3), 319-28.
62. Knekt, P.; Jarvinen, R.; Reunanen, A.; Maatela, J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J., 1996, 312, 478-81. (Pubitemid 26061237)
63. Ghanim, H.; Sia, C. L.; Abuaysheh, S.; Korzeniewski, K.; Patnaik, P.; Marumganti, A.; Chaudhari, A.; Dandona, P. An antiinflammatory and reactive oxygen species suppressive effect of an extract of polygonum cuspidatum containing resveratrol. J. Clin. Endocrinol. Metab., 2010, 91, E1-E8.
64. Petrovaski, G.; Guruswamy, N.; Das, D. K. Resveratrol in cardiovascular health and disease. Ann. Ny. Acad. Sci., 2011, 1215, 22-33.
65. Nicholson, S. K.; Tucker, G. A.; Brameld, J. M. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc. Nutr. Soc., 2008, 67, 42-47. (Pubitemid 351185355)
66. Altman, R. Risk factors in coronary atherosclerosis athero-inflammation: the meeting point. Thromb. J., 2003, 1, 4.
67. Lin, M. T.; Yen, M. L.; Lin, C. Y.; Kuo, M. L. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol. Pharmacol., 2003, 64, 1029-1036.
68. Zou, J. G.; Wang, Z. R.; Huang, Y. Z.; Cao, K. J.; Wu, J. M. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int. J. Mol. Med., 2003, 11, 317-320.
69. O'Leary, K. A.; de Pascual-Tereasa, S.; Needs, P. W.; Bao, Y. P.; O'Brien, N. M.; Williamson, G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat. Res., 2004, 551: 245-254. (Pubitemid 38833512)
70. Fremont, L.; Belguendouz, L.; Delpal, S. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci., 1999, 64, 2511-2521. (Pubitemid 29268427)
71. Godichaud, S.; Krisa, S.; Cocuonne, B.; Dubuisson, L.; Me'rillan, J. M.; Desmouliere, A.; Rosenbaum, J. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grape vine derived polyphenol. Hepatology , 2000, 31, 922-931. (Pubitemid 30169940)
72. Gurusamy, N.; Ray, D.; Lekli, I.; Das, D. K. Red wine antioxidant resveratrol modified cardiac stem cells regenerate infarcted myocardium. J. Cell Mol. Med., 2010, 14, 2235-2239.
73. Lekli, I.; Ray, D.; Mukhrjee, S.; Guruswamy, N.; Mohammad, K. A.; Junasz, B.; Bak, I.; Tosaki, A.; Gherguiceanu, M.; Propescu, L.; Das, D. K. Coordinated autophagy with resveratrol and gamma-Tocotrienol confers synergetic cardioprotection. J. Cell Mol. Med., 2009.
74. Merck Index. 12 ed. Whitehouse Station, NJ: Merck & Co., Inc., 1996.
75. Ameer, B.; Weintraub, RA; Johnson, JV; Yost, RA; Rouseff, RL. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin Pharmacol Ther., 1996, 60, 34-40. (Pubitemid 26279218)
76. Saija, A.; Scalese, M.; Lanza, M.; Marzullo, D.; Bonina, F.; Castelli, F. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radic Biol Med., 1995, 19,481-486.
77. Joshipura, K. J.; Ascherio, A.; Manson, J. E.; Stampfer, M. J.; Rimm, E. B.; Speizer, F. E.; Hennekens, C. H.; Spiegelman, D.; Willett, W. C. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA, 1999, 282, 1233-1239. (Pubitemid 29468494)
78. Gorinstein, S.; Caspi, A.; Libman, I.; Lerner, H. T.; Huang, D.; Leontowizz, H.; Leo, M.; Tashma, Z.; Katrich, E.; Fen, G. S.; Trakhtenberg, S. Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans. J Agric Food Chem., 2006, 54, 1887-1892.
79. Rajadurai, M.; Stanely Mainzen Prince P. Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. Toxicology., 2006, 228(2-3), 259-68. (Pubitemid 44708452)
80. Huong, DTT; Takahashi, Y.; Ide, T. Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids. Nutrition, 2006, 22, 546-552.
81. Corvazier, E.; Maclouf, J. Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochem Biophys Acta., 1985, 835, 315-321. (Pubitemid 15066071)
82. da Silva, E. L.; Tsushida, T.; Terao, J. Inhibition of mammalian 15-lipoxygenase-dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin monoglucosides. Arch Biochem Biophys., 1998, 349,313-320. (Pubitemid 28368676)
83. Wald, N. J.; Law, M. R. Serum cholesterol and ischaemic heart disease. Atherosclerosis, 1995, 118, 1-5.
84. Jeon, S. M.; Park, Y. B.; Choi, M. S. Antihypercholesterolaemic property of naringin alters plasma and tissue lipids,cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. Clin Nutr., 2004, 23, 1025-1034. (Pubitemid 39243016)
85. Newby, A. C.; Zaltsman, A. B. Molecular mechanisms in intimal hyperplasia. J. Pathol., 2000, 190, 300-309. (Pubitemid 30141376)
86. Galis, Z. S.; Muszynski, M.; Sukhova, G. K.; Simon-Morrissey, E.; Linemori, E. N.; Lack, M. W.; Ammento, E.; Libby, P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res., 1994, 75,181-189. (Pubitemid 24187750)
87. Xiuzhen, Han; Dongmei, Ren; Peihong, Fan; Tao, Shen; Hongxiang, Lou. Protective effects of naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells. Euro. J. Pharma., 2008, 581, 47-53.
88. Mithen, R. Glucosinolates-biochemistry, genetics, and biological activity. Plant Growth Regul., 2001, 34, 91-103.
89. Mulcahy, R. T.; Wartman, M. A.; Bailey, H. H.; Gipp, J. J. Constitutive and beta-naphthalone-induced expression of the human gamma-glutamyl cysteine synthetase heavy subunit gene is regulated by a distral antioxidant response element/ TRE sequence. J Biol Chem., 1997, 272, 7445-7454. (Pubitemid 27166457)
90. Murashima, M.; Watanabe, S; Zhuo, X. G.; Vehera, M.; Kurashige, A. Phase 1 study of multiple biomarkers for metabolism and oxidative stress after oneweek intake of broccoli sprouts. Biofactors, 2004, 22, 271-275. (Pubitemid 40921800)
91. W u, L.; Noyan-Ashraf, MH; Facci, M.; Wang, R.; Paterson, PG; Ferrie, A.; Juurlink, BH. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc Natl Acad Sci., 2004, 101, 7094-7099. (Pubitemid 38596448)
92. Molavi, B.; Mehta, JL. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr. Opin. Cardiol., 2004, 19, 488-493. (Pubitemid 39222966)
93. Angeloni, C.; Leoncini, E.; Malaguti, M.; Angelini, S.; Hrelia, P.; Hrelia, S. Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential. J. Agric. Food Chem., 2009, 57, 5615-5622.
94. Wu, L.; Ashraf, M.; Facci, M.; Wang, R.; Paterson, PG; Ferrie, A.; Juurlink, BHJ. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 7094.
95. Noyan-Ashraf, MH; Sadeghinejad, Z.; Juurlink, BH. Dietary approach to decrease aging-related CNS inflammation. Nutr. Neurosci., 2005, 8, 101-110. (Pubitemid 40959651)
96. Yochum, L.; Kushi, L. H.; Meyer, K.; Folsom, A. R. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol., 1999, 149, 943-949. (Pubitemid 29230709)
97. Mukherjee, S.; Gangopadhyay, H.; Das, D. K. Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J. Agric. Food Chem., 2008, 56, 609-17. (Pubitemid 351212593)
98. Das, D. K.; Maulik, N. Conversion of death signal into survival signal by redox signaling. Biochemistry, 2004, 69, 10-17.
99. Barton, D.; Ollis, W. D. Comprehensive Organic Chemistry: The Synthesis and Reactions of Organic Compounds, Pergamon, NewYork, 1979, 3,. 461-477.
100. Vasanthi H. R.; Subhendhu Mukherjee; Dipak, K. Das. Potential Health Benefits of Broccoli-A Chemico-Biological Overview. Mini-Rev Med Chem., 2009, 9,749-759
101. Saba, Adebowale, Bernard; Oridupa, Ayorinde, Olayinka. Search for a novel antioxidant, anti inflammatory, analgesic or anti-proliferative drug: Cucurbitacins hold the ace. J. Med. Plants Res., 2010, 4 (25), 2821-2826, 29.
102. Tannin spitz, T.; Bergman, M.; Grossman S. Cucurbitacin glucosides: Antioxidant and free radical scavenging activities. Biochem, Biophys Res Commun., 2007, 364, 181-186. (Pubitemid 47599438)
103. Haritunians, T.; Gueller, S.; Zhang, L.; Badr, R.; Yin, D.; Xing, H.; Fung, MC; Koeffler, HP. Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells. Leuk. Res., 2008, 32(9), 1366-1373.
104. Agil, A.; Miro, M.; Jimenez, J.; Aneiros, J.; Caracuel, MD; Garcia-Granados, A.; Navarro, MC. Isolation of an anti-hepatotoxic principle from the juice of Ecballium elaterium. Planta Med., 1999, 65, 673-675. (Pubitemid 29503243)
105. Peters, RR; Saleh, TF; Lora, M; Patry, C.; de Brum-Fernandes, AJ; Ribeirodo-Valle, RM. Anti-inflammtory effects of the products from Wilbrandia ebracteata on carrageenan-induced pleurisy in mice. Life Sci., 1999, 64(26), 2429-2437. (Pubitemid 29268418)
106. Blaskovich, MA; Sun, J.; Cantor, A.; Turkson, J.; Jove, R.; Sebti, SM. Discovery of JSI-(cucurbitacin I), A selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Can. Res., 2003, 63, 1270-1279. (Pubitemid 36348705)
107. Jayaprakasam, B.; Seeram, NP; Nair, MG. Anticancer and anti-inflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett., 2003, 189, 11-16. (Pubitemid 35351514)
108. Yesilada, E.; Tanaka, S.; Sezik, E.; Tabata, M. Isolation of an antiinflammatory principle from the fruit juice of Ecballium elaterium, J. Nat. Prod., 1988, 51, 504-508.
109. Kamboj, V. P. Herbal Medicine. Curr Sci., 2000, 78, 35-39
110. Son, I. S.; Kim, J. H.; Sohn, H. Y.; Kim, J. S.; Kwon, C. S. Antioxidative and hypolipidemic effects of Diosgenin, a steroidal saponin of Yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci. Biotech. Biochem., . 2007, 71, 3063-71.
111. Shisodia, S.; Aggarwal, B. B. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through downregulation of Akt, I kappa B kinase activation and NF-kappa-B regulated gene expression. Oncogene, 2006, 9, 1463-1473. (Pubitemid 43361932)
112. Leger, D. Y.; Liagra, B.; Beneytout, J. L. Role of MAPKs and NF-kappaB in diosgenin-induced megakaryocytic differentiation and subsequent apoptosis in HEL cells. Int. J. Onc., 2006, 28, 201-207.
113. Jayachandran, K. S.; Vasanthi, H. R.; Rajamanickama, G. V. Antilipoperoxidative and membrane stabilizing effect of diosgenin, in experimentally induced myocardial infarction. Mol. Cell. Biochem., 2009, 327, 203-210.
114. Jayachandran, K. S.; Vasanthi, H. R.; Rajamanickama, G. V. Flavonoid rich fraction of Dioscorea bulbifera Linn. (Yam) enhances mitochondrial enzymes and antioxidant status and thereby protects heart from isoproterenol induced myocardial infarction. Curr. Pharm. Biotech., 2010, 8, 887-94.
115. Vasanthi, H. R.; Mukhrjee, S.; Ray, D.; Jayachandran, K. S.; Lekli, I.; Das, D. K. Protective role of air potato (Dioscorea bulbifera) of yam family in myocardial ischemic reperfusion injury. Food Funct., 2010, 1, 278-283.
116. Uchida, K.; Takase, H.; Nomura, Y.; Takeda, Ki.; Takeuchi, N.; Ishikawa, Y. Effects of diosgenin and B-sitosterol on bile acids. J. Lipid Res., 1984, 25, 236-245.
117. Kwon, C. S.; Sohn, H. Y.; Kim, S. E.; Kim, J. H.; Son, K. H.; Lec, J. S.; Lim, J. K.; Kim, J. S. Antiobesity effect of Dioscorea nipponica Makino with lipase inhibitory activity in rodents. Biosci. Biotechnol. Biochem., 2003, 67, 1451-1456. (Pubitemid 39251780)
118. Vasanthi, H. R.; Parmeshwari, R. P.; Das, D. K. Multifaceted role of tocotrienols in cardioprotection supports their structure and function relationship. Genes Nutr., 2011, doi 10. 1007/s/12263-011-0227-9.
119. Kamat, J.; Devasagayam, TPA. Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci Lett, 1995, 195,179-182.
120. Pearce, B. C.; Parker, R. A.; Deason M. E. Inhibitors of cholesterol biosynthesis. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydroaphthalene analogues of the tocotrienols. J Med. Chem., 1992, 37, 526-541. (Pubitemid 24094834)
121. Qureshi, A. A.; Qureshi, N.; Wright, JJK; Shen, Z.; Kramer, G.; Gapor, A.; Chang, Y. H.; Dewitt, G.; Ong, ASH; Peterson, D. M.; Bradlow, B. A. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr., 1991, l02, l-6.
122. Qureshi, A. A.; Bradlow, B. A.; Brace L. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids, 1995, 30, 1171-1177.
123. Qureshi A. A.; Pearce, C.; Nor, R. M. Dietary d-Tocopherol attenuates the impact of d-Tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J Nutr., 1996 126: 389-394. (Pubitemid 26060531)
124. Fengjuan, Li; Wenjuan Tan; Zhanfang Kang; Chi-Wai Wong. Tocotrienol enriched palm oil prevents atherosclerosis through modulating the activities of peroxisome proliferators-Activated receptors. Atherosclerosis, 2010, 211, 278-282.
125. Wu, S. J.; Liu, P. L.; Lean-Teik, N. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol. Nutr. Food Res., 2008, 52, 921-929.
126. Ikeda, S.; Tohyama, T.; Yoshimura, H.; Hamamura, K.; Abe, K.; Yamashita, K. Dietary alpha-Tocopherol decreases alpha-Tocotrienol but not gammatocotrienol concentration in rats. J. Nutr., 2003 133, 428-434. (Pubitemid 36172895)
127. Das, M.; Das, S.; Wang, P.; Powell, SR.; Das, D. K. Caviling and proteasome in tocotrienol mediated myocardial protection. Cell Physiol. Biochem., 2008, 22, 287-294.
128. Vasanthi, H. R.; Parmeshwari, R. P.; Das, D. K. Tocotrienols and its role in cardiovascular health-A lead for drug design. Curr Pharm Des,. 2011,17, 88-94.
129. Britton,G. Structure and properties of carotenoids in relation to function. The FASEB Journal, 1995, 9, 155.
130. Jung Sook Seoa; Kyeung Soon Lea; Jung Hyun Jang; Zhejiu Quan; Kyung Mi Yang; Betty Jane Burri. The effects of dietary supplementation of beta carotene on lipid metabolism in streptozotocin induced diabetic rats. J Nutr Res., 2004, 24(12), 1011-1021. (Pubitemid 39643037)
131. Shaish, A.; Daughtery, A.; O'Sullivan, F.; Schonfeld, G.; Heinecke, J. W. Beta carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest., 1995, 96(4), 2075-82.
132. Bellizzi, M. C.; Franklin, M. F.; Duthie, G. G.; James, W. P. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr., 1994, 48, 822-31. (Pubitemid 24344829)
133. Knekt, P.; Reunanen, A.; Jarvinen, R.; Seppanen, R.; Heliovaara, M.; Aromaa, A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol., 1994,139, 1180-9. (Pubitemid 24184411)
134. Gey, K. F.; Stahelin, H. B.; Eichholzer, M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Investig., 1993, 71, 3-6. (Pubitemid 23041967)
135. Morris, D. L.; Kritchevsky, S. B.; Davis, C. E. Serum carotenoids and coronary heart disease: the Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. J Am Med Assoc., 1994, 272, 1439-41. (Pubitemid 24328387)
136. Vajragupta, O.; Boonchoong, P.; Berlinear, L. J. Managanese complexes of curcumin analogues:-evaluation of hydroxyl radical scavenging activity, superoxide dismutase activity and stability towards hydrolysis. Free Radical Res., 2004, 8(3), 303-14. (Pubitemid 38247998)
137. Stahl, W.; Sies, H. Antioxidant activity of carotenoids. Molecular Aspects Med, 2003, 24, 345-351. (Pubitemid 37324647)
138. Stahl, W.; Junghans, B.; De boer E. S.; Oriomonia E. S.; Briuiba, K.; Sies, H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage : synergistic effects of lycopene and lutein. FBBS Lett., 1998, 427, 305-308. (Pubitemid 28225080)
139. Woodwall A. A.; Britton, G.; Jackson, M. J. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxy radicals: relationship between carotenoids structure and protective ability. Biochem. Biophys. Acta, 1997, 1336, 575-586. (Pubitemid 27467060)
140. Upadhyaya, K. R.; Radha, K. S.; Madhyastha, H. K. Cell cycle regulation and induction of apoptosis by beta carotene in U937 and HL-60 leukemia cells. J. Biochem. Mol. Bio., 2007, 40, 1001-1015.
141. Fuhrman, B.; Elis, A.; Aviram, M. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun., 1997, 233: 658-662. (Pubitemid 27217707)